INVO Bioscience (INVO) Misses Q2 EPS by 62c

INVO Bioscience (NASDAQ: INVO) reported Q2 EPS of ($0.62). Revenue for the quarter came in at $1.84 million.

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Uber Is Said To Be In Advanced Talks On Delivery Hero Takeover - Bloomberg
• Arrow Electronics earns Microsoft Azure Virtual Desktop specialization
• Xcel Brands signs licensing deal for Christie Brinkley home decor line